• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Bionano to Report Second Quarter 2023 Financial Results and Host a Conference Call and Webcast on August 9, 2023

    8/2/23 8:00:00 AM ET
    $BNGO
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $BNGO alert in real time by email

    SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) today announced that it will host a conference call and live webcast on Wednesday, August 9, 2023, at 4:30 p.m. Eastern Time to report financial results for the second quarter 2023 and to highlight recent corporate progress.

    Conference Call & Webcast Details

    Date:Wednesday, August 9th, 2023
    Time:4:30 p.m. ET
    Participant Call Link:Registration – Click Here

    Webcast Link:https://edge.media-server.com/mmc/p/kdtv69k5

    Participants may access a live webcast of the call on the Investors page of the Bionano website. A replay of the conference call and webcast will be archived on Bionano's investor relations website at https://ir.bionano.com/ for at least 30 days.

    CONTACTS

    Company Contact:

    Erik Holmlin, CEO

    Bionano Genomics, Inc.

    +1 (858) 888-7610

    [email protected] 

    Investor Relations:

    David Holmes

    Gilmartin Group

    +1 (858) 888-7625

    [email protected] 



    Primary Logo

    Get the next $BNGO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BNGO

    DatePrice TargetRatingAnalyst
    11/15/2024Buy → Neutral
    Ladenburg Thalmann
    9/10/2024Buy → Neutral
    BTIG Research
    1/5/2023$4.00Sector Outperform
    Scotiabank
    12/12/2022$3.50Buy
    BTIG Research
    7/18/2022$12.00Outperform
    Oppenheimer
    More analyst ratings

    $BNGO
    SEC Filings

    See more
    • Amendment: Bionano Genomics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K/A - Bionano Genomics, Inc. (0001411690) (Filer)

      6/18/25 5:15:40 PM ET
      $BNGO
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Bionano Genomics Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders

      8-K - Bionano Genomics, Inc. (0001411690) (Filer)

      6/13/25 4:24:27 PM ET
      $BNGO
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form 10-Q filed by Bionano Genomics Inc.

      10-Q - Bionano Genomics, Inc. (0001411690) (Filer)

      5/14/25 4:11:22 PM ET
      $BNGO
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $BNGO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Twomey Christopher J

      4 - Bionano Genomics, Inc. (0001411690) (Issuer)

      6/12/25 4:51:11 PM ET
      $BNGO
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form 4 filed by Director Vuori Kristiina Md

      4 - Bionano Genomics, Inc. (0001411690) (Issuer)

      6/12/25 4:50:58 PM ET
      $BNGO
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form 4 filed by Director Linney Yvonne

      4 - Bionano Genomics, Inc. (0001411690) (Issuer)

      6/12/25 4:50:47 PM ET
      $BNGO
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $BNGO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Bionano Genomics downgraded by Ladenburg Thalmann

      Ladenburg Thalmann downgraded Bionano Genomics from Buy to Neutral

      11/15/24 7:40:01 AM ET
      $BNGO
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Bionano Genomics downgraded by BTIG Research

      BTIG Research downgraded Bionano Genomics from Buy to Neutral

      9/10/24 7:37:53 AM ET
      $BNGO
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Scotiabank initiated coverage on Bionano Genomics with a new price target

      Scotiabank initiated coverage of Bionano Genomics with a rating of Sector Outperform and set a new price target of $4.00

      1/5/23 7:29:54 AM ET
      $BNGO
      Biotechnology: Laboratory Analytical Instruments
      Industrials